Survival benefit of radical prostatectomy in patients with localized prostate cancer: Estimations of the number needed to treat according to tumor and patient characteristics

Journal of Urology

Volumn 188, Issue 1, 2012, Pages 73-83

  Abdollah, Firas ^a,c   Sun, Maxine ^a   Schmitges, Jan ^a,b   Thuret, Rodolphe ^a,d   Bianchi, Marco ^a,c   Shariat, Shahrokh F ^e   Briganti, Alberto ^c   Jeldres, Claudio ^a   Perrotte, Paul ^a   Montorsi, Francesco ^c   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIV MONTPELLIER   (France)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

comorbidity; prostate; prostatectomy; prostatic neoplasms; SEER program

Indexed keywords

AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COMORBIDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CANADA; EUROPE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; PROGNOSIS; PROPENSITY SCORE; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84862144423     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.03.005     Document Type: Article

References (18)

1. A. Bill-Axelson, L. Holmberg, M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977
2. Y.N. Wong, N. Mitra, G. Hudes Survival associated with treatment vs observation of localized prostate cancer in elderly men JAMA 296 2006 2683
3. F. Abdollah, M. Sun, R. Thuret A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006 Eur Urol 59 2011 88
4. G.L. Lu-Yao, P.C. Albertsen, D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202
5. J.P. Fine, R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496
6. F. Abdollah, M. Sun, J. Schmitges Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort Eur Urol 60 2011 920
7. C.N. Klabunde, A.L. Potosky, J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258
8. P.R. Rosenbaum, D.B. Rubin Reducing bias in observational studies using subclassification on the propensity score J Am Stat Assoc 79 1984 516
9. R.B. D'Agostino Jr, R.B. D'Agostino Sr Estimating treatment effects using observational data JAMA 297 2007 314
10. P.C. Austin Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations Biom J 51 2009 171
11. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265
12. K. Imai, G. King, E.A. Stuart Misunderstanding between experimentalists and observationalists about causal inference J Roy Statist Soc Ser A 171 2008 481
13. T.A. Stukel, E.S. Fisher, D.E. Wennberg Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods JAMA 297 2007 278
14. J.R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141
15. M.R. Cooperberg, A.J. Vickers, J.M. Broering Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer Cancer 116 2010 5226
16. P.C. Albertsen, D.F. Moore, W. Shih Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335
17. Y.N. Wong, S.J. Freedland, B. Egleston The role of primary androgen deprivation therapy in localized prostate cancer Eur Urol 56 2009 609
18. D.Y. Lin, B.M. Psaty, R.A. Kronmal Assessing the sensitivity of regression results to unmeasured confounders in observational studies Biometrics 54 1998 948